Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia
- 1 July 2000
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 356 (9226) , 285-290
- https://doi.org/10.1016/s0140-6736(00)02503-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- THE MANAGEMENT OF HIGH‐RISK LYMPHOBLASTIC LEUKAEMIA IN CHILDRENBritish Journal of Haematology, 2000
- Pharmacogenomics: Translating Functional Genomics into Rational TherapeuticsScience, 1999
- Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.Journal of Clinical Oncology, 1996
- Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.Journal of Clinical Oncology, 1996
- The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions.British Journal of Clinical Pharmacology, 1995
- Unexpected Acute Neurologic Toxicity in the Treatment of Children With Acute Lymphoblastic LeukemiaJNCI Journal of the National Cancer Institute, 1992
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaThe Lancet, 1990
- SEIZURES IN CHILDHOOD LYMPHOBLASTIC LEUKAEMIA PATIENTSThe Lancet, 1984